Thanks for this post, great analysis.
Whilst we're talking about the potential impact of China on TWE, I was looking in the 2020 Annual Report and noticed that Asia's EBIT contribution is sizeable but Net Sales are almost half. I'm not experienced with balance sheets/accounting but trying to learn more, what's the implication? Does it mean because of tax and other costs in the region, regardless of the huge sales volume it doesn't end up being as dominant to TWE's futures as all the articles we've seen this year suggest?
- Forums
- ASX - By Stock
- TWE
- Buffett Style Valuation
Buffett Style Valuation, page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TWE (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.90 |
Change
-0.110(1.00%) |
Mkt cap ! $8.844B |
Open | High | Low | Value | Volume |
$11.05 | $11.09 | $10.84 | $20.37M | 1.867M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 11701 | $10.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.96 | 9267 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 11701 | 10.900 |
4 | 11547 | 10.890 |
6 | 107971 | 10.880 |
2 | 22901 | 10.870 |
4 | 12497 | 10.860 |
Price($) | Vol. | No. |
---|---|---|
10.960 | 9267 | 3 |
10.970 | 8332 | 3 |
10.980 | 6243 | 1 |
10.990 | 16545 | 2 |
11.000 | 100 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
TWE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online